J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge

摘要

The consensus conference was organized with the assistance of the Chinese Heart Rhythm Society and funded by an unrestricted educational grant from Buchang Pharmaceuticals. We acknowledge support by grants from NHLBI (HL47678) and Wistar and Martha Morris (CA); Sharpe- Strumia Research Foundation (GXY); National Natural Science Foundation of China (NSFC-81370289) (GXY); the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program (MJA); Ministry of Health, Labor and Welfare of Japan for Clinical Research on Intractable Diseases H24-033, H26-040, H27-032 (MH, HM, WS); Finnish Academy of Science and Sigrid Juselius Foundation, Helsinki, Finland (HH); JSPS KAKENHI (24591051 and 15K09082) (HM); Ministry of Science and Technology of China (2013BAI09B02, 2013DFB30310) (CM); University of Padua, Italy (TRANSAC) (DC); Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences (AW); Investment of the Future Grant ANR-10-IAHU-04, Agence National de la Recherche, French Government (FS). Dr. Antzelevitch was a consultant for Gilead Sciences and has received grant funding and speaker fees from Gilead Sciences and Buchang Pharma. Dr. Yan is a consultant for GlaxoSmithKline and has received funding from GlaxoSmithKline, Johnson & Johnson, Novartis, Astellas, and Pfizer. Dr. Sacher is a consultant to St. Jude Medical, Boston Scientific, and Bayer Healthcare, and has received speaking honoraria from Medtronic, Biosense Webster, LilaNova, Boehringer Ingelheim, and Buchang Pharma. Dr. Viskin is a member of the European Scientific Advisory Board of Boston Scientific. Dr. Huikuri received funding from Medtronic Bakken Research Center. Dr. Morita is affiliated with a department endowed by Japan Medtronic Inc. Dr. Wilde is a member of the scientific advisory board of Sorin. Dr. Ackerman is a consultant for Boston Scientific, Gilead Sciences, Medtronic, and St. Jude Medical and has received royalties from Transgenomic Inc.